Tularemia: MRIGlobal awarded DTRA contract to develop vaccine
by Press Release from Outbreak News Today on (#1M9QD)
MRIGlobal yesterday announced that it has been awarded a $6.2 million, 5-year program from the Defense Threat Reduction Agency (DTRA) for the development of a vaccine for tularemia. The award continues a long-standing international co-operation to develop a tularemia vaccine. Tularemia is a disease of animals and humans caused by the bacterium Francisella tularensis. Rabbits, ["]
